Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Accuray Inc (NASDAQ:ARAY)

5.04
Delayed Data
As of 4:00pm ET
 +0.11 / +2.23%
Today’s Change
4.80
Today|||52-Week Range
7.54
-25.33%
Year-to-Date
Accuray's (ARAY) TomoTherapy System Uptake on the Rise
Jun 24 / Zacks.com - Paid Partner Content
Accuray Wins 7 TomoTherapy Orders from NHS, Stock Up
Jun 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.93
Today’s open4.96
Day’s range4.96 - 5.07
Volume398,836
Average volume (3 months)657,232
Market cap$399.0M
Dividend yield--
Data as of 4:00pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)-8.51%
Earnings growth (this year)--
Earnings growth (next 5 years)-259.10%
Revenue growth (last year)+2.81%
P/E ratioNM
Price/Sales1.39
Price/Book5.17

Competitors

 Today’s
change
Today’s
% change
ENTLEntellus Medical Inc+0.05+0.28%
NVDQNovadaq Technologies...+0.14+1.47%
IMMUImmunomedics Inc+0.18+9.00%
AXGNAxoGen Inc+0.34+5.45%
Data as of 4:00pm ET, 06/28/2016

Financials

Next reporting dateAugust 18, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$379.8M
Annual profit (last year)-$40.2M
Net profit margin-10.59%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joshua H. Levine
Chief Operating Officer &
Executive Vice President
Kelly J. Londy
Corporate headquarters
Sunnyvale, California

Forecasts

Partner Offers

Search for Jobs